#WeightRegain hashtag - Bluesky

@bariatricpaths.bsky.social

1 week ago

Part 2 with Mel from OSLP gets into trauma, regain, and the mental load no one prepares you for.

Listen now.

#Bariatric #WeightRegain #MentalHealth #GLP1 #Healing

1 0 0 0

Biohacking Pathway

@biohackingpathway.bsky.social

2 weeks ago

#WeightLossDrugs #LongTermEffects #HealthConsequences #BodyComposition #MuscleLoss #BoneLoss #WeightRegain #CaseStudy #wellnessadvocate #wellnesscoaching #wellnessfitness #wellnesscenter #HealthRisks #MedicalScience

0 0 0 0

Biohacking Pathway

@biohackingpathway.bsky.social

1 month ago

#WeightLossDrugs #LongTermEffects #HealthConsequences #BodyComposition #MuscleLoss #BoneLoss #WeightRegain #CaseStudy #wellnessadvocate #wellnesscoaching #wellnessfitness #wellnesscenter #HealthRisks #MedicalScience

0 0 0 0

Daily Trend Mirror

@latestnewsofficial.bsky.social

2 months ago

Kelly Parish Says She’ll Be on Mounjaro for Life After Weight Regain Kelly Parish shares why she will stay on Mounjaro for life after regaining weight, her size 12 figure, managing sweet cravings, and using the weight loss medication alongside calorie counting.

Kelly Parish Says She’ll Be on Mounjaro for Life After Weight Regain
#KellyParish #Mounjaro #WeightLossJourney #WeightRegain #Size12Goals #HealthAndFitness #WeightLossMedication #CalorieCounting #SweetCravings #LifelongWeightManagement
dailytrendmirror.com/trending-new...

0 0 0 0

BioNews Central

@bionewscentral.com

2 months ago

Stopping GLP-1 weight loss drugs linked to weight regain and reversal of heart health markers – BioNews Central Stopping GLP-1 weight loss drugs is followed by weight regain and a reversal of the beneficial effects on heart and metabolic health markers. ...

Stopping #GLP1 #WeightLossDrugs is followed by #WeightRegain and a reversal of the beneficial effects on #heart and #MetabolicHealth markers.
#GLP1Drugs #HeartHealth

0 0 0 0

pharmaphorum

@pharmaphorum.bsky.social

2 months ago

Study finds weight returns more quickly in GLP-1 users People who use drugs like GLP-1 agonists to lose weight regain it more quickly than those who use a conventional approach of diet and exercise.

People who use drugs like #GLP1 agonists to lose #weightregain it more quickly than those who use a conventional approach of #diet and #exercise, according to a new study.

0 0 0 0

Biohacking Pathway

@biohackingpathway.bsky.social

3 months ago

#WeightLossDrugs #LongTermEffects #HealthConsequences #BodyComposition #MuscleLoss #BoneLoss #WeightRegain #CaseStudy #wellnessadvocate #wellnesscoaching #wellnessfitness #wellnesscenter #HealthRisks #MedicalScience

0 0 0 0

Biohacking Pathway

@biohackingpathway.bsky.social

4 months ago

#WeightLossDrugs #LongTermEffects #HealthConsequences #BodyComposition #MuscleLoss #BoneLoss #WeightRegain #CaseStudy #wellnessadvocate #wellnesscoaching #wellnessfitness #wellnesscenter #HealthRisks #MedicalScience

0 0 0 0

@d-and-d-world.bsky.social

4 months ago

Amgen’s new data reinforce weight regain after GLP-1 discontinuation Amgen’s exec and study’s author explain that data shows stopping GLP-1s leads to weight regain, while managing LDL-C significantly reduces cardiovascular event risk.

Stopping GLP-1s leads to weight regain, new data from Amgen shows. For high-risk patients, managing LDL-C is key to cutting cardiovascular events.

#News #GLP1 #weightregain #obesity #cardiovascularhealth #LDL #Interviews

0 0 0 0

Phalguni Deswal

@phalguniddw.bsky.social

4 months ago

Amgen’s new data reinforce weight regain after GLP-1 discontinuation Amgen’s exec and study’s author explain that data shows stopping GLP-1s leads to weight regain, while managing LDL-C significantly reduces cardiovascular event risk.

Stopping GLP-1s leads to weight regain, new data from Amgen shows. For high-risk patients, managing LDL-C is key to cutting cardiovascular events.

#News #GLP1 #weightregain #obesity #cardiovascularhealth #LDL #Interviews

0 0 0 0

Biohacking Pathway

@biohackingpathway.bsky.social

5 months ago

#WeightLossDrugs #LongTermEffects #HealthConsequences #BodyComposition #MuscleLoss #BoneLoss #WeightRegain #CaseStudy #wellnessadvocate #wellnesscoaching #wellnessfitness #wellnesscenter #HealthRisks #MedicalScience

0 0 0 0

Cardiovascular Diseases Research Institute

@tumscvdri.bsky.social

5 months ago

The role of glucagon-like peptide-1 receptor agonists in weight regain treatment or prevention after bariatric surgery: a systematic review and meta-analysis - Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity Background Weight regain (WR) and insufficient weight loss (WL) occur in 20–25% of patients after bariatric surgery due to various factors. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have shown promise in promoting WL; however, evidence regarding their effectiveness in managing WL and preventing WR post-bariatric surgery remains limited. Objective This study aims to evaluate the role of GLP-1RAs in treating and preventing WR following bariatric surgery. Methods A systematic search was conducted across PubMed, Scopus, and Web of Science for studies assessing the impact of GLP-1RAs on WR after bariatric surgery. Results Our search identified 27 original studies, with 10 included in the meta-analysis involving 769 participants (392 treated with GLP-1RAs). The mean age was 44.05 years, with 30.47% male. The time interval from surgery to the initiation of GLP-1RAs treatment ranged from 1.5 to 86.7 months, with treatment durations between 4 and 12 months. The analysis showed significantly greater WL in the GLP-1RAs group compared to placebo (SMD = 0.82, 95% CI 0.23 to 1.42). Subgroup analysis for treatment durations ≤ 6 months indicated a higher WL in the GLP-1RAs group (SMD = 0.79, 95% CI 0.25 to 1.34). Adverse events were primarily gastrointestinal, with nausea significantly more frequently in the GLP-1RAs group (OR = 2.01, 95% CI 1.24 to 3.27). Conclusion GLP-1RAs effectively promote WL among participants experiencing WR after bariatric surgery. Initiating GLP-1RAs therapy shortly after surgery may help prevent WR. Further research is warranted to explore long-term outcomes and optimize treatment protocols for this patient population. Graphical Abstract

GLP-1 receptor agonists (GLP-1RAs) boost weight loss and help fight #WeightRegain after #BariatricSurgery, according to the latest #MetaAnalysis. Early treatment shows greater effects. Most side effects are mild and gastrointestinal. More long-term data needed! link.springer.com/article/10.1...

3 0 0 0

Biohacking Pathway

@biohackingpathway.bsky.social

6 months ago

#WeightLossDrugs #LongTermEffects #HealthConsequences #BodyComposition #MuscleLoss #BoneLoss #WeightRegain #CaseStudy #wellnessadvocate #wellnesscoaching #wellnessfitness #wellnesscenter #HealthRisks #MedicalScience